BackDurect Overview

Durect Current Cash

Latest current cash for DRRX: $6.5M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$6.50M
↓ 58.44% YoYΔ $-9.14M vs prior year quarter

Peer trimmed avg / median

Loading

Durect Current Cash History

Loading

Durect vs. peers: Current Cash Comparison

Loading

Durect Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Durect (DRRX) FAQ

Durect (DRRX) currently reports a current cash of $6.5M as of June 2025. That compares with $16M in the prior-year period — down 58.4% year over year. Use the charts on this page to explore Durect's current cash history and peer comparisons.

Durect's current cash decreased from $16M to $6.5M — a 58.4% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Durect reported $6.5M in current cash as of June 2025. That compares with $16M in the prior-year period — down 58.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $6.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Durect, and consider following DRRX for alerts when major investors trade the stock.

Durect is classified in the Healthcare sector. On current cash, it currently shows $6.5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DRRX with unrelated industries.